Carbonic Anhydrase IX antibody [66.4.C2]
GTX01814
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetCA9
Overview
- SupplierGeneTex
- Product NameCarbonic Anhydrase IX antibody [66.4.C2]
- Delivery Days Customer9
- Application Supplier NoteIHC-P: 1:100-1:200. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID66.4.C2
- ConjugateUnconjugated
- Gene ID768
- Target nameCA9
- Target descriptioncarbonic anhydrase 9
- Target synonymsCAIX, MN, carbonic anhydrase 9, CA-IX, P54/58N, RCC-associated antigen G250, RCC-associated protein G250, carbonate dehydratase IX, carbonic anhydrase IX, carbonic dehydratase, membrane antigen MN, pMW1, renal cell carcinoma-associated antigen G250
- HostMouse
- IsotypeIgG2a
- Protein IDQ16790
- Protein NameCarbonic anhydrase 9
- Scientific DescriptionCarbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA IX is a transmembrane protein and is one of only two tumor-associated carbonic anhydrase isoenzymes known. It is expressed in all clear-cell renal cell carcinoma, but is not detected in normal kidney or most other normal tissues. It may be involved in cell proliferation and transformation. This gene was mapped to 17q21.2 by fluorescence in situ hybridization, however, radiation hybrid mapping localized it to 9p13-p12. [provided by RefSeq, Jun 2014]
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Ansari AN, Bobos M, Shih S, et al. Renal Cell Carcinoma Antigen Expression in Primary Cutaneous Endocrine Mucinous Carcinomas: A Case Series of 14 Patients and Review of the Literature. Am J Dermatopathol. 2019,41(8):571-577. doi: 10.1097/DAD.0000000000001370Read this paper
- Fadare O, Desouki MM, Gwin K, et al. Clear Cell Renal Cell Carcinoma Metastatic to the Gynecologic Tract: A Clinicopathologic Analysis of 17 Cases. Int J Gynecol Pathol. 2018,37(6):525-535. doi: 10.1097/PGP.0000000000000466Read this paper
- Braxton DR, Saxe D, Damjanov N, et al. Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma". Hum Pathol. 2017,62:232-241. doi: 10.1016/j.humpath.2017.02.001Read this paper
- Lin WC, Chen JH, Westphalen A, et al. Primary Renal Rhabdomyosarcoma in an Adolescent With Tumor Thrombosis in the Inferior Vena Cava and Right Atrium: A Case Report and Review of the Literature. Medicine (Baltimore). 2016,95(21):e3771. doi: 10.1097/MD.0000000000003771Read this paper
- Tajima S, Waki M, Doi W, et al. Acquired cystic disease-associated renal cell carcinoma with a focal sarcomatoid component: Report of a case showing more pronounced polysomy of chromosomes 3 and 16 in the sarcomatoid component. Pathol Int. 2015,65(2):89-94. doi: 10.1111/pin.12232Read this paper





![IHC-P analysis of human stomach tissue using GTX01918 Carbonic Anhydrase IX antibody [TH22]. Note intense membrane and cytoplasmic staining of the deep glands.](https://www.genetex.com/upload/website/prouct_img/normal/GTX01918/GTX01918_20200811_IHC-P_9_w_23053121_493.webp)